A B H Bakker

Summary

Affiliation: Crucell Holland BV
Country: The Netherlands

Publications

  1. ncbi First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity
    A B H Bakker
    Crucell Holland BV, Leiden, The Netherlands
    Vaccine 26:5922-7. 2008

Detail Information

Publications1

  1. ncbi First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity
    A B H Bakker
    Crucell Holland BV, Leiden, The Netherlands
    Vaccine 26:5922-7. 2008
    ..All subjects had adequate (>0.5IU/mL) RVNA levels from day 14 onwards when combined with rabies vaccine. CL184 appears promising as an alternative to RIG in PEP...